Mai Hashimoto

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Identification of a novel long-acting 4’-modified nucleoside reverse transcriptase inhibitor against HBV”.

Identification of a novel long-acting 4’-modified nucleoside reverse transcriptase inhibitor against HBV

Journal of Hepatology(2020)10.1016/j.jhep.2020.12.006

N/A

0DataRank · unranked

28 citations

Sanae Hayashi, Hiroki Kumamoto, Hiromi Ogata-Aoki, Debananda Das, David Venzon +12 more

Pharmacokinetic Properties of Orally Administered 4′-Cyano-2′-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats

Biological and Pharmaceutical Bulletin(2020)10.1248/bpb.b20-00372

N/A

0DataRank · unranked

2 citations

Kazuaki Taguchi, Shuhei Imoto, Keishi Yamasaki, Hiroaki Mitsuya, Masaki Otagiri +1 more

Pharmacokinetics of 4′-cyano-2′-deoxyguanosine, a novel nucleoside analog inhibitor of the resistant hepatitis B virus, in a rat model of chronic kidney disease

Journal of Infection and Chemotherapy(2020)10.1016/j.jiac.2020.12.014

N/A

0DataRank · unranked

0 citations

Kazuaki Taguchi, Shuhei Imoto, Keishi Yamasaki, Hiroaki Mitsuya, Masaki Otagiri +1 more